BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matusewicz L, Czogalla A, Sikorski AF. Attempts to use statins in cancer therapy: An update. Tumour Biol 2020;42:1010428320941760. [PMID: 32662332 DOI: 10.1177/1010428320941760] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Vasseur S, Guillaumond F. Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance. Oncogenesis 2022;11:46. [PMID: 35945203 DOI: 10.1038/s41389-022-00420-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Bhatnagar R, Dixit NM, Yang EH, Sallam T. Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.925816] [Reference Citation Analysis]
3 Scott SS, Greenlee AN, Matzko A, Stein M, Naughton MT, Zaramo TZ, Schwendeman EJ, Mohammad SJ, Diallo M, Revan R, Shimmin G, Tarun S, Ferrall J, Ho TH, Smith SA. Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity. Heart Failure Clinics 2022. [DOI: 10.1016/j.hfc.2022.02.003] [Reference Citation Analysis]
4 Ahmad Malik J, Jan R, Ahmed S, Anwar S. Breast Cancer Drug Repurposing a Tool for a Challenging Disease. Drug Repurposing - Molecular Aspects and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.101378] [Reference Citation Analysis]
5 Abdelfatah E, Kukar M, Mukherjee S, Groman A, Yendamuri S. The anticancer effect of statins in obese esophageal cancer patients undergoing esophagectomy. J Surg Oncol 2022. [PMID: 35476878 DOI: 10.1002/jso.26892] [Reference Citation Analysis]
6 Rovini A, Heslop KA, Maldonado EN. Mitochondria and Tumor Metabolic Flexibility: Mechanisms and Therapeutic Perspectives. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00090-6] [Reference Citation Analysis]
7 Patnaik SK, Petrucci C, Barbi J, Seager RJ, Pabla S, Yendamuri S. Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC. JTO Clin Res Rep 2021;2:100254. [PMID: 34877556 DOI: 10.1016/j.jtocrr.2021.100254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mathien S, Tesnière C, Meloche S. Regulation of Mitogen-Activated Protein Kinase Signaling Pathways by the Ubiquitin-Proteasome System and Its Pharmacological Potential. Pharmacol Rev 2021;73:263-96. [PMID: 34732541 DOI: 10.1124/pharmrev.120.000170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Duarte D, Vale N. Combining repurposed drugs to treat colorectal cancer. Drug Discov Today 2021:S1359-6446(21)00406-2. [PMID: 34592446 DOI: 10.1016/j.drudis.2021.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wujak M, Kozakiewicz A, Ciarkowska A, Loch JI, Barwiolek M, Sokolowska Z, Budny M, Wojtczak A. Assessing the Interactions of Statins with Human Adenylate Kinase Isoenzyme 1: Fluorescence and Enzyme Kinetic Studies. Int J Mol Sci 2021;22:5541. [PMID: 34073952 DOI: 10.3390/ijms22115541] [Reference Citation Analysis]
11 Giacomini I, Gianfanti F, Desbats MA, Orso G, Berretta M, Prayer-Galetti T, Ragazzi E, Cocetta V. Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy. Front Oncol 2021;11:682911. [PMID: 34109128 DOI: 10.3389/fonc.2021.682911] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
12 Aschenbrenner B, Negro G, Savic D, Sorokin M, Buzdin A, Ganswindt U, Cemazar M, Sersa G, Skvortsov S, Skvortsova I. Simvastatin is effective in killing the radioresistant breast carcinoma cells. Radiol Oncol 2021;55:305-16. [PMID: 33939900 DOI: 10.2478/raon-2021-0020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Haney SL, Varney ML, Chhonker Y, Talmon G, Smith LM, Murry DJ, Holstein SA. In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway. Pharmacol Res 2021;167:105528. [PMID: 33667685 DOI: 10.1016/j.phrs.2021.105528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jentzsch V, Davis JAA, Djamgoz MBA. Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers (Basel) 2020;12:E3096. [PMID: 33114159 DOI: 10.3390/cancers12113096] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]